{
  "id": 5392423,
  "title": "Merck's top dealmaker signals more M&A as Keytruda's patent cliff nears",
  "url": "https://urgent.news/2026/09/03/mercks-top-dealmaker-signals-more-m-a-as-keytrudas-patent-cliff-nears",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-03T18:49:58.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/mercks-top-dealmaker-signals-more-ma-as-keytrudas-patent-cliff-nears/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Merck CEO Robert Davis has been landing deals “with urgency” over the last few years in an effort to shore up the pipeline ahead of Keytruda’s upcoming patent cliff. But make no mistake: The company ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}